(For treatment side effects and complications only)
Dabrafenib Malignant Melanoma Protocol V1.1
Dabrafenib & Trametinib Protocol V1.2
Dacarbazine protocol
Encorafenib & Binimetinib Malignant Melanoma Protocol V1.1
Entrectinib - NTRK Gene Fusion-positive Solid Tumours ROS1-positive NSCLC Protocol V1.1
Ipilimumab Advanced Melanoma V1.1
Nivolumab Adjuvant Treatment of Melanoma and Gastro-Oesophageal Cancer Protocol V1.2
Systemic Treatment Algorithm for Metastatic or Unresectable Malignant Melanoma V1.0
talimogene laherparepvec protocol
Tebentafusp (Managed Access Program) For the treatment of metastatic uveal melanoma V1.0